The test, although it may cause claustrophobia with the mask being performed, is useful for advancing in new ways of diagnosing and detecting any type of cancer
cancer will soon reveal it simple breath test, after the researchers started with clinical examination to see if s molecule in the mouth can identify the disease
In the tests he is running Cancer Research in Great Britain, breath samples were collected from 1,500 people in the hope of discovering fragrance molecules Volatile organic compoundsAnd (VOC).
All cells are produced by HOS every day, but if theirs are metabolism changes with factors like cancer, releasing a different pattern.
If the test is successful, that would mean cancer can be quickly detected before the spread, when it is easier to heal and when the chances of survival are higher.
Teacher Rebecca Fitzgerald, a major trial investigator at the UK Cancer Research Center in Cambridge, explained that there is an urgent need to develop new tools such as this breath test that could help detect and diagnose cancer earlier, giving patients the best chance to survive your illness.
"Through this clinical trial, we hope to find the patterns in the breath needed to detect cancer earlier, which is the next key step in the development of this technology," he said. Telegraph.
A biopsy breathing test was developed by the Owlstone Medical biotechnology company headquartered in Cambridge and the first to work on multiple forms of cancer, paving the way for a universal breathing test that could be quickly applied by a general practitioner. .
The trial will begin with suspicious patients esophagus and stomach cancer and then it will expand on prostate cancer, kidney, bladder, liver and pancreas in the following months.
Trial is recruiting patients for Addenbrooke Hospital, in Cambridge, which their physician sent for suspicion of suffering from these specific types of cancer.
It will get a breath test before other diagnostic tests. Patients will breathe for a test for 10 minutes to collect the sample, which will then be processed in the Owlstone Medical Breath Laboratory in Cambridge, UK.
Rebecca Coldrick, 54, from Cambridge, was one of the first to apply for research.
At 30, he was diagnosed Barrett's esophagusa condition in which abnormal gout cells are being treated, which can be early cancer warning.
At present, Mrs. Coldrick needs an invasive endoscopy to detect the disease every two years, but if the new breath test is successful, she will no longer have to go through the procedure.
Currently, the percentage of detected late-stage carcinomas. when survival is bad. Such methods could be key to the fight against the disease.